Font:
VE

VENUSREM / NSE / Biotechnology & Drugs

Venus Remedies

INR 1,633.5Not available (5.00%) 1D
Last updated: 2026-06-04T19:16:35.368227+00:00
Price Chart

1Y Price Trend

OpenNot available
HighNot available
LowNot available
CloseNot available
VolumeNot available
ChangeNot available
Change %Not available
OHLC data unavailablePrice candles will render once this stock has historical data.

Key Information

Ticker SymbolVENUSREM
Current Price1,633.5
52-Week High1,555.8
52-Week Low415.4
Market Cap2,188.31
Beta0.85
Volume0.12
ISININE411B01019
Day High1,637.1
Day Low1,559.15
Open1,637.1

Recommendations

Target High1,559.15

Target Low417.65

Target Mean0

Target Median0

Risk Metrics

Overall RiskHigh risk

Board Risk54.94

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 9 December 20256 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy today - Latent View Analytics, Cantabil Retail India Limited, Gujarat Ambuja Exports, Venus Remedies, and Jindal Stainless.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 15 July 202511 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy today: CEAT, V I P Industries, Blue Jet Healthcare, HEG, and Venus Remedies.

Venus Remedies stock jumps over 14% to 8-week high on FDA approval for anti-mircrobial resistance therapy1 year ago
Market news

Shares of Venus Remedies rose 14.3% to ₹ 356.65 after the US FDA granted QIDP designation to its product VRP-034, targeting bloodstream infections. This designation offers regulatory benefits, highlighting the need for safer polymyxin therapies. The stock has rebounded 12% this month.

Smallcap pharma stock hits over 8% upper circuit after securing marketing nod for chemotherapy drugs; do you own?2 years ago
Market news

Venus Remedies gained over 8 per cent today after securing marketing authorisation for three variants of chemotherapy drugs in Israel and Colombia

Venus Remedies shares locked at 5% upper circuit as German arm gets Spanish regulator nod to market Meropenem in Spain2 years ago
Market news

Venus Remedies' German subsidiary Venus Pharma GmbH has received this approval for 500mg, 1g and 2g injections of this last-recourse antibiotic.

FAQ

Stock FAQs

What is the NSE symbol for Venus Remedies?

Venus Remedies trades on NSE with the symbol VENUSREM. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Venus Remedies share price and chart?

You can track Venus Remedies share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Venus Remedies?

Yes. ShareKeyX displays available financial statements for Venus Remedies using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Venus Remedies?

Historical OHLC candles for Venus Remedies are not available in the current source yet. The chart section will update once candles are available.

What sector or industry does Venus Remedies belong to?

Venus Remedies is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Venus Remedies?

Yes. ShareKeyX shows the latest available stock news for Venus Remedies from the connected stock news source.